Zoetis | ZTS - Interest Expense On Debt

Stock Price
116.87
Daily Change
0.81 0.70%
Monthly
0.14%
Yearly
-23.85%
Q2 Forecast
114.37

Zoetis reported $57M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
AbbVie USD 740M 40M Jun/2025
Align Technology USD 2M 660K Mar/2023
Bayer EUR 675M 87M Dec/2025
Bristol-Myers Squibb USD 432M 48M Dec/2025
Charles River Laboratories USD 23.78M 1.63M Dec/2025
Coherus Biosciences USD 2.25M 76K Dec/2025
Dentsply International USD 22M 1000K Dec/2025
Eli Lilly USD 114.7M 134.3M Sep/2025
Henry Schein USD 39M 1000K Dec/2025
Idexx Laboratories USD 10.08M 1.24M Sep/2025
Illumina USD 25M 0 Sep/2025
IQVIA Holdings USD 193M 4M Dec/2025
J&J USD 43M 25M Mar/2026
Laboratory Of America USD 55M 1000K Dec/2025
Merck USD 412M 85M Dec/2025
Neogen USD 13.9M 356K Dec/2025
Pacira USD 3.89M 387K Dec/2025
Perrigo USD 10.08B 10.04B Sep/2025
Pfizer USD 711M 59M Dec/2025
Phibro Animal Health USD 11.91M 191K Dec/2025
Quest Diagnostics USD 69M 2M Sep/2025
Sanofi EUR 178M 203M Mar/2026
Sanofi EUR -25M 99.78M Dec/2025
Zoetis USD 57M 1000K Dec/2025